Strict No-needle policy declares by the Athletics Federation of India

The Athletics Federation of India (AFI) decided to impose a strict ‘No-Needle’ policy at all the national camps and training centers in the country. Recently two of their athletes were sent back home on charges of possession of needles during the recent Commonwealth Games.

The AFI becomes the one of the first among National Sports Federations (NSFs) to announce a ‘No-Needle’ policy, has drawn up a protocol and circulated to all the athletes at national camps and training centers across the country.

Adille Sumariwalla, AFI President stated that the ‘No-Needle’ policy has come into effect immediately.

To implement this policy effectively, the AFI formed a three-member committee of coaches, which has been empowered to search the rooms of the athletes. AFI ensures that this policy should be publicizing at its best among athletes so that nobody is in possession of a needle or any forbidden substance. AFI will take strict action will be taken against those who are found violating this policy. Disciplinary Committee of the AFI will handle all the cases of needle possession.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory